Last reviewed · How we verify

NCT05487508

Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients

Completed Phase 4 Last updated 4 August 2022
What this trial tests

Phase 4 trial testing Dexamethasone in Coronary Artery Disease in 120 participants. Completed in 31 March 2019.

Timeline
1 July 2018
Primary endpoint
31 January 2019
31 March 2019

Quick facts

Lead sponsorIndonesia University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment120
Start date1 July 2018
Primary completion31 January 2019
Estimated completion31 March 2019
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

Adults 18 to 75, any sex, with Coronary Artery Disease or Inflammatory Response. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, double-blind, randomized controlled clinical trial comparing four groups: placebo conventional coronary artery bypass graft (CCABG) group, dexamethasone CCABG group, placebo off-pump coronary artery bypass (OPCAB) group, and dexamethasone OPCAB group. The primary outcomes of this study is comprised of presence of arrhythmia, major adverse cardiac events (MACE), myocardial infarction, stroke, renal failure, respiratory failure, inflammation, and death. These primary outcomes were assessed during the surgery, 18 hours post surgery, every day during the hospital stay, 14 days and 30 days post surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dexamethasone

Trials testing the same drug.

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05487508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing